CCK2 antibodies (Aphton/University of Nottingham)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCCK2 antibodies (Aphton/University of Nottingham)
Drug Alias NameGRE1 antiserum (Aphton/University of Nottingham)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCholecystokinin B receptor antagonists
TargetsCholecystokinin B receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Nottingham
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A